Safety of Fentanyl TAIFUN Treatment

Clinical trial NCT00822614 · UNKNOWN

Trial details

NCT number: NCT00822614
Sponsor: Akela Pharma, Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Breakthrough Cancer Pain

Start date: 2008-12-01
Primary completion: 2009-12-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.